Study of Pathways Curriculum for Use With WPD

This study has been completed.
Sponsor:
Collaborator:
Portland State University
Information provided by (Responsible Party):
Dena Hassouneh, Oregon Health and Science University
ClinicalTrials.gov Identifier:
NCT00788814
First received: November 10, 2008
Last updated: October 15, 2012
Last verified: October 2012
  Purpose

Study to assess the efficacy of a modified Pathways curriculum in treating depressive symptoms in women with physical disabilities.


Condition Intervention
Depression
Behavioral: Pathways

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Women Physical Disability and Depression: Communities Responding Now!

Resource links provided by NLM:


Further study details as provided by Oregon Health and Science University:

Primary Outcome Measures:
  • Center for Epidemiologic Studies Depression Scale (CES-D) [ Time Frame: pre-test, post-test weeks, 12, 18, 24 ] [ Designated as safety issue: No ]

Enrollment: 80
Study Start Date: June 2008
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Control
Control group
Behavioral: Pathways
Strength-based curriculum addressing depression in women with with physical disabilities

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Women with physical disability requiring accommodation for major mobility limitations
  • CES-D score of 16 or higher -

Exclusion Criteria:

  • Active suicidality
  • Diagnosis of Schizophrenia, Schizoaffective D/O, Psychosis NOS
  • Currently receiving other psychotherapy -
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00788814

Locations
United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97236
Sponsors and Collaborators
Oregon Health and Science University
Portland State University
Investigators
Principal Investigator: Dena M Hassouneh, PhD Oregon Health and Science University
  More Information

No publications provided

Responsible Party: Dena Hassouneh, Associate Professor, Oregon Health and Science University
ClinicalTrials.gov Identifier: NCT00788814     History of Changes
Other Study ID Numbers: 1R01MH079818-01A1, 1R01MH079818-01A1
Study First Received: November 10, 2008
Last Updated: October 15, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 17, 2014